IL74071A0 - Dihydropyridine derivatives and pharmaceutical compositions containing them - Google Patents

Dihydropyridine derivatives and pharmaceutical compositions containing them

Info

Publication number
IL74071A0
IL74071A0 IL74071A IL7407185A IL74071A0 IL 74071 A0 IL74071 A0 IL 74071A0 IL 74071 A IL74071 A IL 74071A IL 7407185 A IL7407185 A IL 7407185A IL 74071 A0 IL74071 A0 IL 74071A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
compositions containing
dihydropyridine derivatives
dihydropyridine
derivatives
Prior art date
Application number
IL74071A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL74071A0 publication Critical patent/IL74071A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Furan Compounds (AREA)
IL74071A 1984-01-18 1985-01-16 Dihydropyridine derivatives and pharmaceutical compositions containing them IL74071A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848401288A GB8401288D0 (en) 1984-01-18 1984-01-18 Therapeutic agents

Publications (1)

Publication Number Publication Date
IL74071A0 true IL74071A0 (en) 1985-04-30

Family

ID=10555153

Family Applications (1)

Application Number Title Priority Date Filing Date
IL74071A IL74071A0 (en) 1984-01-18 1985-01-16 Dihydropyridine derivatives and pharmaceutical compositions containing them

Country Status (15)

Country Link
US (1) US4548935A (da)
EP (1) EP0150939A1 (da)
JP (1) JPS60161981A (da)
KR (1) KR870000912B1 (da)
AU (1) AU556636B2 (da)
DK (1) DK21785A (da)
ES (1) ES8604928A1 (da)
FI (1) FI850199A7 (da)
GB (1) GB8401288D0 (da)
HU (1) HU193918B (da)
IL (1) IL74071A0 (da)
PH (1) PH21329A (da)
PL (1) PL143334B1 (da)
PT (1) PT79830B (da)
YU (1) YU7685A (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0233228A1 (en) * 1985-08-06 1987-08-26 Boehringer Mannheim Italia S.P.A. Pharmaceutically active 2-thiomethyl-substituted-1,4-dihydropyridines
GB8527698D0 (en) * 1985-11-09 1985-12-11 Pfizer Ltd Dihydropyridine antiischaemic & antihypertensive agents
IT1197012B (it) * 1986-07-29 1988-11-25 Boehringer Biochemia Srl 2-(aciltio) metil diidropiridine, un processo per la loro preparazione e composizioni farmaceutiche che le contengono
JPH0688973B2 (ja) * 1987-03-12 1994-11-09 京都薬品工業株式会社 1,4−ジヒドロピリジン誘導体
IE64995B1 (en) * 1987-07-14 1995-09-20 Warner Lambert Co Novel benzothiophenes having antiallergic activity and both novel and other selected benzothiophenes having activity for treating acute respiratory distress syndrome
US6653481B2 (en) * 2000-12-29 2003-11-25 Synthon Bv Process for making amlodipine
SE0200979D0 (sv) * 2002-03-28 2002-03-28 Astrazeneca Ab New compounds
GB0610804D0 (en) * 2006-05-31 2006-07-12 Portela & Ca Sa New crystal forms
JP2011506315A (ja) * 2007-12-05 2011-03-03 バイアル−ポルテラ アンド シーエー,エス.エー. 新たな塩、及び結晶形

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4307103A (en) * 1978-09-08 1981-12-22 Fujisawa Pharmaceutical Co., Ltd. Dihydropyridine derivative, processes for preparation thereof and pharmaceutical composition comprising the same
CS228917B2 (en) * 1981-03-14 1984-05-14 Pfizer Method of preparing substituted derivatives of 1,4-dihydropyridine
JPS57175166A (en) * 1981-04-23 1982-10-28 Banyu Pharmaceut Co Ltd Carbamoyloxyalkyl-1,4-dihydropyridine derivative and its preparation
EP0100189B1 (en) * 1982-07-22 1986-05-28 Pfizer Limited Dihydropyridine anti-ischaemic and antihypertensive agents

Also Published As

Publication number Publication date
HUT37755A (en) 1986-02-28
FI850199L (fi) 1985-07-19
ES539592A0 (es) 1986-02-16
DK21785A (da) 1985-07-19
KR850005438A (ko) 1985-08-26
PT79830A (en) 1985-02-01
DK21785D0 (da) 1985-01-17
PL143334B1 (en) 1988-02-29
ES8604928A1 (es) 1986-02-16
PT79830B (en) 1986-12-09
PL251584A1 (en) 1985-12-03
PH21329A (en) 1987-10-13
GB8401288D0 (en) 1984-02-22
KR870000912B1 (ko) 1987-05-06
US4548935A (en) 1985-10-22
FI850199A7 (fi) 1985-07-19
HU193918B (en) 1987-12-28
FI850199A0 (fi) 1985-01-16
AU556636B2 (en) 1986-11-13
YU7685A (en) 1987-10-31
EP0150939A1 (en) 1985-08-07
AU3775185A (en) 1985-07-25
JPS60161981A (ja) 1985-08-23

Similar Documents

Publication Publication Date Title
IL75326A0 (en) Quinolone derivatives and pharmaceutical compositions containing them
NZ220345A (en) Imidazoquinolinylether derivatives and pharmaceutical compositions containing them
IL74758A0 (en) Acyltripeptides and pharmaceutical compositions containing them
NZ211031A (en) 6-substituted-4-dialkylaminotetrahindole derivatives and pharmaceutical compositions
NZ213821A (en) Piperidine derivatives and pharmaceutical compositions
IL74865A0 (en) 9a-aza-9a-homoerythromycin derivatives and pharmaceutical compositions containing them
NZ216647A (en) Furanone derivatives and compositions
NZ221284A (en) Dihydropyridine derivatives and pharmaceutical compositions
IL71187A0 (en) 1,4-dihydropyridine derivatives and pharmaceutical compositions containing them
IL75943A0 (en) 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
IL82205A (en) Substituted alkane-sulfonamidophenyl derivatives and pharmaceutical compositions containing them
IL76188A (en) 3-aralkylidene-hydroxy-flavanone derivatives and pharmaceutical compositions containing them
NZ210818A (en) 8-alpha-acylaminoergoline derivatives and pharmaceutical compositions
IL86711A0 (en) 5-pyrimidinecarboxamide derivatives and pharmaceutical compositions containing them
IL75411A0 (en) Dihydropyridines and pharmaceutical compositions containing them
NZ225466A (en) 1-aminoalkyl-1h-indole derivatives and pharmaceutical compositions containing certain derivatives thereof
GB2167414B (en) Flavolignan derivatives and pharmaceutical compositions containing them
IL75242A0 (en) Pharmaceutical compositions containing dihydropyridines and their preparation
IL75427A0 (en) Dihydropyridines and pharmaceutical compositions containing them
GB2142021B (en) 1 4-dihydropyridine derivatives their preparation and pharmaceutical compositions containing them
IL80540A0 (en) Dihydropyridine derivatives and pharmaceutical compositions containing them
IL78642A0 (en) Dihydropyridines and pharmaceutical compositions containing them
DE3569526D1 (en) Glutarimide derivatives, their preparation and pharmaceutical compositions containing them
IL74667A (en) Spiro-oxazolidones,-thiazolidones and-imidazolidones and pharmaceutical compositions containing them
NZ212946A (en) Quinoline derivatives and pharmaceutical compositions